Therapeutic Monitoring of Mycophenolate Mofetil in Organ Transplant Recipients: Is It Necessary?

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.5, 2002-01, pp. : 319-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate mofetil/prednisone/tacrolimus: Hafnia alvei pyelonephritis in a renal transplant recipient?: case report

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

The use of mycophenolate mofetil in liver transplant recipients

By Detry Olivier de Roover Arnaud Delwaide Jean Meurisse Michel Honoré Pierre

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 1949-1957

Informa Healthcare

Access to resources Recommend Favorite

Individualisation of mycophenolate mofetil dose in renal transplant recipients

By van Hest Reinier M Hesselink Dennis A Vulto Arnold G Mathot Ron AA van Gelder Teun

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 361-376

Informa Healthcare

Access to resources Recommend Favorite

Is protection for participants in QI initiatives necessary?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 285, 2000-01 ,pp. : 4-5

Adis International

Access to resources Recommend Favorite

Cytomegalovirus Infection and Abdominal Pain with Mycophenolate Mofetil: Is There a Link?

By Gallagher H. Andrews P.A.

Drug Safety, Vol. 24, Iss. 6, 2001-01 ,pp. : 405-412

Adis International

Access to resources Recommend Favorite